Template for reporting results of biomarker testing of specimens from patients with carcinoma of the breast.
From the Department of Pathology, St Jude Medical Center, Fullerton, California (Dr Fitzgibbons); the Department of Pathology, Brigham and Women's Hospital, Boston, Massachusetts (Dr Dillon); the Department of Pathology, Kaiser Permanente-Los Angeles Medical Center, Los Angeles, California (Dr Alsabeh); the Department of Pathology, Jefferson Hospital, Jefferson Hills, Pennsylvania (Dr Berman); the Breast Oncology Program, University of Michigan Comprehensive Cancer Center, Ann Arbor (Dr Hayes); the Department of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, New York (Dr Hicks); the Division of Surgical Oncology, Massachusetts General Hospital, Boston (Dr Hughes); and the Department of Anatomic Pathology, Sunnybrook Health Sciences Centre, University of Toronto, Toronto, Ontario, Canada (Dr Nofech-Mozes).
Patrick L
PL
Fitzgibbons
Deborah A
DA
Dillon
Randa
R
Alsabeh
Michael A
MA
Berman
Daniel F
DF
Hayes
David G
DG
Hicks
Kevin S
KS
Hughes
Sharon
S
Nofech-Mozes
D014408:Biomarkers, Tumor / Q000378:metabolism*; D001943:Breast Neoplasms / Q000175:diagnosis* / Q000378:metabolism; D005260:Female; D006801:Humans; D007150:Immunohistochemistry; D017403:In Situ Hybridization; D010338:Pathology, Clinical / Q000379:methods*; D018719:Erb-b2 Receptor Tyrosine Kinases / Q000378:metabolism; D011960:Receptors, Estrogen / Q000378:metabolism; D011980:Receptors, Progesterone / Q000378:metabolism; D012107:Research Design / Q000592:standards*
D014408:Biomarkers, Tumor; D018719:Erb-b2 Receptor Tyrosine Kinases; D011960:Receptors, Estrogen; D011980:Receptors, Progesterone; C508053:ERBB2 protein, human